Covered recipient · General Payments record
ASMA M KAZI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2025
$570.08
- Reported across 26 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $205.85 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $45.25 | 1 |
| Xeris Pharmaceuticals, Inc. | $37.26 | 2 |
| ABBVIE INC. | $31.03 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $28.22 | 1 |
| Novo Nordisk AS | $27.91 | 1 |
| PFIZER INC. | $21.38 | 1 |
| Lilly USA, LLC | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.03 | 07/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202172501 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $28.22 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225601016 | CMS |
| Lilly USA, LLC | $14.80 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186522867 | CMS |
| Medtronic, Inc. | $45.25 | 05/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219890719 | CMS |
| Novo Nordisk Inc | $27.91 | 04/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189138814 | CMS |
| PFIZER INC. | $21.38 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230112693 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.20 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250150090 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.06 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250150092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.